Abstract
Rights: ALLOWED · cc-by · Source: journal-auto-sync:external:CROSSREF_ISSN
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Devin A. Sindeldecker
Abstract
Rights: ALLOWED · cc-by · Source: journal-auto-sync:external:CROSSREF_ISSN
Authors
Institutions
Provenance
crossref
Confidence 100%
ror
Confidence 99%
ror
Confidence 99%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
openalex
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Cystic fibrosis and Pseudomonas aeruginosa: the host-microbe interface
10.1128/cmr.00138-18 · 2019
Pseudomonas prosthetic joint infections: a review of 102 episodes
10.7150/jbji.15722 · 2016
Chronic wound infections: the role of Pseudomonas aeruginosa and Staphylococcus aureus
10.1586/14787210.2015.1023291 · 2015
Tolerance and resistance of Pseudomonas aeruginosa biofilms to antimicrobial agents-how P. aeruginosa can escape antibiotics
10.3389/fmicb.2019.00913 · 2019
Multidrug tolerance of biofilms and persister cells
2008
Multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii: resistance mechanisms and implications for therapy
10.1586/eri.09.108 · 2010
Biofilm formation and dispersal and the transmission of human pathogens
10.1016/j.tim.2004.11.004 · 2005
Persister cells
10.1146/annurev.micro.112408.134306 · 2010
Progressive increase in antibiotic resistance of gram-negative bacterial isolates. Walter Reed Hospital, 1976 to 1980: specific analysis of gentamicin, tobramycin, and amikacin resistance
10.1001/archinte.1983.00350110053015 · 1983
Sudden increase in Pseudomonas aeruginosa nosocomial strains with broad host range transfer of antibiotic resistance
10.1179/joc.2001.13.6.607 · 2001
Confidence 95%
doaj
Confidence 92%
datacite
Confidence 0%
Global incidence of multidrug-resistant tuberculosis
10.1086/505877 · 2006
Prevalence of multidrug-resistant organisms recovered at a military burn center
10.1016/j.burns.2009.10.013 · 2010
Prevalence, resistance mechanisms, and susceptibility of multidrug-resistant bloodstream isolates of Pseudomonas aeruginosa
10.1128/aac.01446-09 · 2010
High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection
10.1126/science.288.5469.1251 · 2000
Adaptive resistance to aminoglycoside antibiotics in Pseudomonas aeruginosa
10.1099/00222615-29-1-41 · 1989
Aminoglycoside resistance in Pseudomonas aeruginosa
10.1128/aac.49.2.479-487.2005 · 2005
Aminoglycoside resistance of Pseudomonas aeruginosa in cystic fibrosis results from convergent evolution in the mexZ gene
10.1136/thoraxjnl-2015-208027 · 2017
Antibiotic tolerance facilitates the evolution of resistance
10.1126/science.aaj2191 · 2017
Molecular mechanisms of fluoroquinolone resistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients
10.1128/aac.44.3.710-712.2000 · 2000
Gentamicin resistance in clinical-isolates of Pseudomonas aeruginosa associated with diminished gentamicin accumulation and no detectable enzymatic modification
10.7164/antibiotics.29.743 · 1976
Inactivation of kanamycin, neomycin, and streptomycin by enzymes obtained in cells of Pseudomonas aeruginoa
10.1128/am.16.9.1276-1281.1968 · 1968
Gentamicin resistance in strains of Pseudomonas aeruginosa mediated by enzymatic N-acetylation of the deoxystreptamine moiety
10.1021/bi00755a013 · 1972
Inactivation of dihydrostreptomycin by Pseudomonas aeruginosa
10.1111/j.1348-0421.1971.tb00596.x · 1971
Expression of the MexXY aminoglycoside efflux pump and presence of an aminoglycoside-modifying enzyme in clinical Pseudomonas aeruginosa isolates are highly correlated
10.1128/aac.01166-20 · 2020
The prevalence of aminoglycoside-modifying enzyme genes among Pseudomonas aeruginosa strains isolated from burn patients
2017
Aminoglycoside resistance mechanisms in clinical isolates of Pseudomonas aeruginosa from the Canary Islands
10.1016/s0934-8840(00)80008-0 · 2000
Mechanisms of fluoroquinolone and aminoglycoside resistance in keratitis-associated Pseudomonas aeruginosa
10.1089/mdr.2018.0218 · 2019
In vivo host environment alters Pseudomonas aeruginosa susceptibility to aminoglycoside antibiotics
10.3389/fcimb.2017.00083 · 2017
The effects of active efflux pumps on antibiotic resistance in Pseudomonas aeruginosa
10.1007/s11274-014-1692-2 · 2014
Effect of efflux pump inhibition on Pseudomonas aeruginosa transcriptome and virulence
10.1038/s41598-017-11892-9 · 2017
Interplay between MexAB-OprM and MexEF-OprN in clinical isolates of Pseudomonas aeruginosa
10.1038/s41598-018-34694-z · 2018
Novel inducers of the expression of multidrug efflux pumps that trigger Pseudomonas aeruginosa transient antibiotic resistance
10.1128/aac.01095-19 · 2019
Structure of Pseudomonas aeruginosa ribosomes from an aminoglycoside-resistant clinical isolate
10.1073/pnas.1909831116 · 2019
Analysis of the Pseudomonas aeruginosa aminoglycoside differential resistomes allows defining genes simultaneously involved in intrinsic antibiotic resistance and virulence
10.1128/aac.00185-19 · 2019
The Pseudomonas aeruginosa pan-genome provides new insights on its population structure, horizontal gene transfer, and pathogenicity
10.1093/gbe/evy259 · 2019
Mechanisms and clinical relevance of bacterial heteroresistance
10.1038/s41579-019-0218-1 · 2019
Evaluation of heteroresistance to polymyxin B among carbapenem-susceptible and -resistant Pseudomonas aeruginosa
10.1099/jmm.0.059220-0 · 2013
Heteroresistance to carbapenems in invasive Pseudomonas aeruginosa infections
10.1016/j.ijantimicag.2017.10.014 · 2018
Mechanisms of heteroresistance and resistance to imipenem in Pseudomonas aeruginosa
10.2147/idr.s249475 · 2020
Antimicrobial heteroresistance: an emerging field in need of clarity
10.1128/cmr.00058-14 · 2015
Diagnosis of biofilm infections in cystic fibrosis patients
10.1111/apm.12689 · doi-reference
Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and alternative therapeutic strategies
10.1016/j.biotechadv.2018.11.013 · doi-reference
Emergence of antibiotic resistance Pseudomonas aeruginosa in intensive care unit; a critical review
10.1016/j.gendis.2019.04.001 · doi-reference
Mechanisms of antibiotic resistance in bacterial biofilms
10.1078/1438-4221-00196 · doi-reference
Reaction-diffusion theory explains hypoxia and heterogeneous growth within microbial biofilms associated with chronic infections
10.1038/npjbiofilms.2016.12 · doi-reference
Active starvation responses mediate antibiotic tolerance in biofilms and nutrient-limited bacteria
10.1126/science.1211037 · doi-reference
Starvation, together with the SOS response, mediates high biofilm-specific tolerance to the fluoroquinolone ofloxacin
10.1371/journal.pgen.1003144 · doi-reference
The extracellular matrix protects Pseudomonas aeruginosa biofilms by limiting the penetration of tobramycin
10.1111/1462-2920.12155 · doi-reference
Contributions of antibiotic penetration, oxygen limitation, and low metabolic activity to tolerance of Pseudomonas aeruginosa biofilms to ciprofloxacin and tobramycin
10.1128/aac.47.1.317-323.2003 · doi-reference
Evolution of the Pseudomonas aeruginosa quorum-sensing hierarchy
10.1073/pnas.1819796116 · doi-reference
The RhlR quorum-sensing receptor controls Pseudomonas aeruginosa pathogenesis and biofilm development independently of its canonical homoserine lactone autoinducer
10.1371/journal.ppat.1006504 · doi-reference
Light-Mediated decreases in cyclic di-GMP levels inhibit structure formation in Pseudomonas aeruginosa biofilms
10.1128/jb.00117-20 · doi-reference
Cyclic-di-GMP and oprF are involved in the response of Pseudomonas aeruginosa to substrate material stiffness during attachment on polydimethylsiloxane (PDMS)
10.3389/fmicb.2018.00110 · doi-reference
Cyclic di-GMP: second messenger extraordinaire
10.1038/nrmicro.2016.190 · doi-reference
Psl produced by mucoid Pseudomonas aeruginosa contributes to the establishment of biofilms and immune evasion
10.1128/mbio.00864-17 · doi-reference
PelA and PelB proteins form a modification and secretion complex essential for Pel polysaccharide-dependent biofilm formation in Pseudomonas aeruginosa
10.1074/jbc.m117.812842 · doi-reference
Pseudomonas aeruginosa biofilms: host response and clinical implications in lung infections
10.1165/rcmb.2017-0321tr · doi-reference
Recent perspectives on the molecular basis of biofilm formation by Pseudomonas aeruginosa and approaches for treatment and biofilm dispersal
10.1007/s12223-018-0585-4 · doi-reference
Biofilm development
10.1128/microbiolspec.mb-0001-2014 · doi-reference
Comparison of detection methods for heteroresistant vancomycin-intermediate Staphylococcus aureus, with the population analysis profile method as the reference method
10.1128/jcm.01128-10 · doi-reference
Novel aminoglycoside-tolerant phoenix colony variants of Pseudomonas aeruginosa
10.1128/aac.00623-20 · doi-reference
Agmatine accumulation by Pseudomonas aeruginosa clinical isolates confers antibiotic tolerance and dampens host inflammation
10.1099/jmm.0.000928 · doi-reference
Phenazine production promotes antibiotic tolerance and metabolic heterogeneity in Pseudomonas aeruginosa biofilms
10.1038/s41467-019-08733-w · doi-reference
A chemosensory system that regulates biofilm formation through modulation of cyclic diguanylate levels
10.1073/pnas.0507170102 · doi-reference
Characterization of colony morphology variants isolated from Pseudomonas aeruginosa biofilms
10.1128/aem.71.8.4809-4821.2005 · doi-reference
Constitutive production of c-di-GMP is associated with mutations in a variant of Pseudomonas aeruginosa with altered membrane composition
10.1126/scisignal.2005943 · doi-reference
Pseudomonas aeruginosa rugose small-colony variants have adaptations that likely promote persistence in the cystic fibrosis lung
10.1128/jb.00119-09 · doi-reference
YfiBNR mediates cyclic di-GMP dependent small colony variant formation and persistence in Pseudomonas aeruginosa
10.1371/journal.ppat.1000804 · doi-reference
The FleQ protein from Pseudomonas aeruginosa functions as both a repressor and an activator to control gene expression from the pel operon promoter in response to c-di-GMP
10.1093/nar/gks384 · doi-reference
Identification of FleQ from Pseudomonas aeruginosa as a c-di-GMP-responsive transcription factor
10.1111/j.1365-2958.2008.06281.x · doi-reference
Second messenger regulation of biofilm formation: breakthroughs in understanding c-di-GMP effector systems
10.1146/annurev-cellbio-101011-155705 · doi-reference
Regulation of cellulose synthesis in Acetobacter xylinum by cyclic diguanylic acid
10.1038/325279a0 · doi-reference
Autolysis and autoaggregation in Pseudomonas aeruginosa colony morphology mutants
10.1128/jb.184.23.6481-6489.2002 · doi-reference
Pseudomonas biofilm formation and antibiotic resistance are linked to phenotypic variation
10.1038/416740a · doi-reference
Self-generated diversity produces "insurance effects" in biofilm communities
10.1073/pnas.0407460101 · doi-reference
Small colony variants of staphylococcus aureus - review
10.1007/s12223-010-0089-3 · doi-reference
Small-colony variants of Pseudomonas aeruginosa in cystic fibrosis
10.1086/598644 · doi-reference
Dissociation in Pseudomonas aeruginosa
10.1128/jb.87.5.1003-1010.1964 · doi-reference
Persister cells, dormancy and infectious disease
10.1038/nrmicro1557 · doi-reference
Emergence of Pseudomonas aeruginosa strains producing high levels of persister cells in patients with cystic fibrosis
10.1128/jb.01651-09 · doi-reference